As the president, chief executive, and founder of Celera Genomics cra (nyse: cra - news - people), he is a kind of ready-made capitalist hero.

FORBES: Celera's worth still up in the air

Now, however, the company is positioning itself to become vitally important to the stampede of companies searching to make the jumble of genetic code listed by Celera Genomics cra (nyse: cra - news - people) and the Human Genome Project into drugs and, eventually, money.

FORBES: Orchid Biosciences Not Yet In The Black

The collection of ordered human genes uncovered jointly by Celera Genomics cra (nyse: cra - news - people) and the federal government's Human Genome Project has the potential to make drug discovery faster and easier by allowing scientists to more quickly figure out what chemicals inside the body a drug has to stop, boost or replace.

FORBES: Rosetta Inpharmatics Reads Genome As Recipe For Drugs